BACKGROUND: Thyroid cancer incidence has risen steadily over the last few decades in most of the developed world, but information on incidence trends in developing countries is limited. Sao Paulo, Brazil, has one of the highest rates of thyroid cancer worldwide, higher than in the United States. We examined thyroid cancer incidence patterns using data from the Sao Paulo Cancer Registry (SPCR) in Brazil and the National Cancer Institute's Surveillance Epidemiology End Results (SEER) program in the United States. METHODS: Data on thyroid cancer cases diagnosed during 1997-2008 were obtained from SPCR (n=15,892) and SEER (n=42,717). Age-adjusted and age-specific rates were calculated by sex and histology and temporal patterns were compared between the two populations. RESULTS: Overall incidence rates increased over time in both populations and were higher in Sao Paulo than in the United States among females (SPCR/SEER incidence rate ratio [IRR]=1.65) and males (IRR=1.23). Papillary was the most common histology in both populations, followed by follicular and medullary carcinomas. Incidence rates by histology were consistently higher in Sao Paulo than in the United States, with the greatest differences for follicular (IRR=2.44) and medullary (IRR=3.29) carcinomas among females. The overall female/male IRR was higher in Sao Paulo (IRR=4.17) than in SEER (IRR=3.10) and did not change over time. Papillary rates rose over time more rapidly in Sao Paulo (annual percentage change=10.3% among females and 9.6% among males) than in the United States (6.9% and 5.7%, respectively). Regardless of sex, rates rose faster among younger people (<50 years) in Sao Paulo, but among older people (≥50 years) in the United States. The papillary to follicular carcinoma ratio rose from <3 to >8 among both Sao Paulo males and females, in contrast to increases from 9 to 12 and from 6 to 7 among U.S.males and females, respectively. CONCLUSIONS: Increased diagnostic activity may be contributing to the notable rise in incidence, mainly for papillary type, in both populations, but it is not likely to be the only reason. Differences in iodine nutrition status between Sao Paulo and the U.S. SEER population might have affected the observed incidence patterns.
BACKGROUND:Thyroid cancer incidence has risen steadily over the last few decades in most of the developed world, but information on incidence trends in developing countries is limited. Sao Paulo, Brazil, has one of the highest rates of thyroid cancer worldwide, higher than in the United States. We examined thyroid cancer incidence patterns using data from the Sao Paulo Cancer Registry (SPCR) in Brazil and the National Cancer Institute's Surveillance Epidemiology End Results (SEER) program in the United States. METHODS: Data on thyroid cancer cases diagnosed during 1997-2008 were obtained from SPCR (n=15,892) and SEER (n=42,717). Age-adjusted and age-specific rates were calculated by sex and histology and temporal patterns were compared between the two populations. RESULTS: Overall incidence rates increased over time in both populations and were higher in Sao Paulo than in the United States among females (SPCR/SEER incidence rate ratio [IRR]=1.65) and males (IRR=1.23). Papillary was the most common histology in both populations, followed by follicular and medullary carcinomas. Incidence rates by histology were consistently higher in Sao Paulo than in the United States, with the greatest differences for follicular (IRR=2.44) and medullary (IRR=3.29) carcinomas among females. The overall female/male IRR was higher in Sao Paulo (IRR=4.17) than in SEER (IRR=3.10) and did not change over time. Papillary rates rose over time more rapidly in Sao Paulo (annual percentage change=10.3% among females and 9.6% among males) than in the United States (6.9% and 5.7%, respectively). Regardless of sex, rates rose faster among younger people (<50 years) in Sao Paulo, but among older people (≥50 years) in the United States. The papillary to follicular carcinoma ratio rose from <3 to >8 among both Sao Paulo males and females, in contrast to increases from 9 to 12 and from 6 to 7 among U.S.males and females, respectively. CONCLUSIONS: Increased diagnostic activity may be contributing to the notable rise in incidence, mainly for papillary type, in both populations, but it is not likely to be the only reason. Differences in iodine nutrition status between Sao Paulo and the U.S. SEER population might have affected the observed incidence patterns.
Authors: E Negri; L Dal Maso; E Ron; C La Vecchia; S D Mark; S Preston-Martin; A McTiernan; L Kolonel; Y Yoshimoto; F Jin; G Wingren; M Rosaria Galanti; L Hardell; E Glattre; E Lund; F Levi; D Linos; C Braga; S Franceschi Journal: Cancer Causes Control Date: 1999-04 Impact factor: 2.506
Authors: I Szabolcs; J Podoba; J Feldkamp; O Dohan; I Farkas; M Sajgó; K I Takáts; M Góth; L Kovács; K Kressinszky; P Hnilica; G Szilágyi Journal: Clin Endocrinol (Oxf) Date: 1997-07 Impact factor: 3.478
Authors: Glaucia C Duarte; Eduardo K Tomimori; Rosângela A Boriolli; Jerenice E Ferreira; Regina M Catarino; Rosalinda Y A Camargo; Geraldo Medeiros-Neto Journal: Arq Bras Endocrinol Metabol Date: 2005-03-08
Authors: J G Hollowell; N W Staehling; W H Hannon; D W Flanders; E W Gunter; G F Maberly; L E Braverman; S Pino; D T Miller; P L Garbe; D M DeLozier; R J Jackson Journal: J Clin Endocrinol Metab Date: 1998-10 Impact factor: 5.958
Authors: A Flores-Rebollar; I Pérez-Díaz; S Lagunas-Bárcenas; B García-Martínez; R Rivera-Moscoso; R Fagundo-Sierra Journal: Acta Otorhinolaryngol Ital Date: 2018-06 Impact factor: 2.124
Authors: Carolina C P S Janovsky; Rui M B Maciel; Cleber P Camacho; Rosalia P Padovani; Claudia C Nakabashi; Ji H Yang; Eduardo Z Malouf; Elza S Ikejiri; M Conceição O C Mamone; Jairo Wagner; Danielle M Andreoni; Rosa Paula M Biscolla Journal: Eur Thyroid J Date: 2015-11-24
Authors: Cari M Kitahara; Michael Gamborg; Amy Berrington de González; Thorkild I A Sørensen; Jennifer L Baker Journal: Cancer Res Date: 2013-11-18 Impact factor: 12.701
Authors: Kassia B Reuters; Maria C O C Mamone; Elsa S Ikejiri; Cleber P Camacho; Claudia C D Nakabashi; Carolina C P S Janovsky; Ji H Yang; Danielle M Andreoni; Rosalia Padovani; Rui M B Maciel; Felipe A B Vanderlei; Rosa P M Biscolla Journal: Eur Thyroid J Date: 2018-04-27